Fluor (FLR) Form 144 Filed for 30,000-Share Sale on NYSE

Rhea-AI Filing Summary

Fluor Corporation insider filing on Form 144 reports a proposed sale of 30,000 common shares through Merrill Lynch (Dallas) with an aggregate market value of $1,200,000.00, estimated to be sold on 09/02/2025 on the NYSE. The shares were originally received as restricted stock awards from Fluor on 03/06/2024 (14,760 shares) and 03/06/2023 (15,240 shares). The filer previously sold 21,200 shares on 06/16/2025 for gross proceeds of $1,061,075.01. The filer certifies no undisclosed material adverse information concerning the issuer.

Positive

• Transparent disclosure of proposed sale under Rule 144 with broker, share count, and market value provided
• Origin of shares clearly identified as restricted stock awards from Fluor Corporation (2023 and 2024 grants)
• Prior sales disclosed (21,200 shares sold on 06/16/2025 for $1,061,075.01), showing consistency in reporting

Negative

• Insider sale of 30,000 shares valued at $1,200,000 increases available supply and may be viewed negatively by some investors
• No additional context provided about the filer’s role or motivation for sale beyond statutory attestation

Insights

Securities Analyst

TL;DR Insider intends to sell 30,000 FLR shares (~$1.2M) after recent sale of 21,200 shares; modestly increases public float.

This Form 144 shows a non-executive or executive-holder disposing of equity awarded as restricted stock over two grant dates (2023 and 2024). The proposed sale size relative to the 161,664,371 shares outstanding is small (~0.0186%), implying limited direct dilution or float pressure. Prior sale on 06/16/2025 for ~$1.06M indicates ongoing monetization of awarded shares rather than a single large liquidation event. Materiality to investors is limited but worth noting for short-term liquidity or sentiment signals.

Corporate Governance Expert

TL;DR Insider disposing of awarded restricted stock could reflect routine liquidity; absence of disclosed material adverse information is standard certification.

The filing documents sales aggregated pursuant to Rule 144 and discloses grant origins and dates. That the shares derive from equity awards emphasizes compensation-to-liquidity conversion rather than secondary market transfers from unrelated parties. The filer’s attestation of no undisclosed material information follows statutory requirement; there is no indication in this filing of unusual governance events, related-party transactions, or regulatory concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 13355 NOEL ROAD SUITE 700 DALLAS TX 75240	30000	1200000.00	161664371	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/06/2024	RESTRICTED STOCK	FLUOR CORPORATION			14760	03/06/2024	EQUITY AWARD
COMMON	03/06/2023	RESTRICTED STOCK	FLUOR CORPORATION			15240	03/06/2023	EQUITY AWARD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STACY DILLOW 6700 LAS COLINAS BLVD IRVING TX 75039	COMMON	06/16/2025	21200	1061075.01

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for FLR report?

The filing reports a proposed sale of 30,000 common shares of Fluor (FLR) via Merrill Lynch on 09/02/2025 with aggregate market value $1,200,000.00.

When were the shares to be sold originally acquired?

The shares were acquired as restricted stock awards from Fluor on 03/06/2024 (14,760 shares) and 03/06/2023 (15,240 shares).

Has the filer recently sold Fluor shares?

Yes, the filer sold 21,200 shares on 06/16/2025 for gross proceeds of $1,061,075.01.

Which broker will handle the sale and where will the shares trade?

The broker is Merrill Lynch, 13355 Noel Road, Suite 700, Dallas TX and the sale is expected on the NYSE.

Does the filer assert any undisclosed material information about Fluor?

The filer signs a certification representing that they do not know of any material adverse information about the issuer that has not been publicly disclosed.